mci 154 has been researched along with Coronary Disease in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 4 (80.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mori, M; Takaoka, H; Takeuchi, M; Yokoyama, M | 1 |
| Hata, K; Hayashi, Y; Mori, M; Takaoka, H; Takeuchi, M; Yamakawa, H; Yokoyama, M | 1 |
| Abe, Y; Kitada, Y; Narimatsu, A | 1 |
| Abe, Y; Kitada, Y; Narimatsu, A; Tobe, A | 1 |
| Brooks, HL; Gross, GJ; Preuss, KC; Shimshak, TM; Warltier, DC; Wynsen, JC | 1 |
1 trial(s) available for mci 154 and Coronary Disease
| Article | Year |
|---|---|
Lusitropic effects of a Ca2+ sensitization with a new cardiotonic agent, MCI-154, on diseased human hearts.
Topics: Adult; Aged; Angina Pectoris; Calcium; Cardiac Catheterization; Cardiotonic Agents; Coronary Disease; Diastole; Dobutamine; Female; Humans; Male; Middle Aged; Myocardial Contraction; Myocardial Ischemia; Myocardium; Pyridazines; Stimulation, Chemical; Ventricular Function, Left | 1995 |
4 other study(ies) available for mci 154 and Coronary Disease
| Article | Year |
|---|---|
Oxygen-saving effect of a new cardiotonic agent, MCI-154, in diseased human hearts.
Topics: Aged; Cardiotonic Agents; Constriction, Pathologic; Coronary Disease; Dobutamine; Energy Metabolism; Female; Hemodynamics; Humans; Male; Middle Aged; Myocardial Contraction; Myocardium; Oxygen Consumption; Pyridazines; Ventricular Function, Left; Ventricular Pressure | 1997 |
Beneficial effect of MCI-154, a cardiotonic agent, on ischemic contractile failure and myocardial acidosis of dog hearts: comparison with dobutamine, milrinone and pimobendan.
Topics: Acidosis; Animals; Cardiotonic Agents; Coronary Disease; Dobutamine; Dogs; Female; Hemodynamics; Hydrogen-Ion Concentration; Male; Milrinone; Myocardial Contraction; Pyridazines; Pyridones | 1992 |
Improvement of postischemic contractile dysfunction of dog heart by MCI-154, a novel cardiotonic agent.
Topics: Adenosine Triphosphate; Animals; Calcium; Cardiotonic Agents; Coronary Disease; Dobutamine; Dogs; Female; Hemodynamics; Male; Milrinone; Myocardial Contraction; Myocardium; Pyridazines; Pyridones; Ventricular Function, Left | 1991 |
Stimulation of myocardium during reperfusion injury by a new inotrope-vasodilator agent, MCI-154.
Topics: Animals; Coronary Disease; Dogs; Heart; Hemodynamics; Myocardial Contraction; Myocardium; Pyridazines; Stimulation, Chemical; Time Factors; Vasodilator Agents | 1987 |